Franklin Resources’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$804K Sell
44,975
-223,640
-83% -$4.89M ﹤0.01% 2270
2025
Q4
$7.25M Buy
268,615
+51,651
+24% +$1.45M ﹤0.01% 1263
2025
Q3
$6.56M Sell
216,964
-310,075
-59% -$9.89M ﹤0.01% 1326
2025
Q2
$14.1M Buy
+527,039
New +$14.2M ﹤0.01% 1027

Other funds holding CAI

Franklin Resources's CAI Position: Q1 2026 in Review

Franklin Resources reduced its Caris Life Sciences (CAI) stake by 83% in Q1 2026, selling an estimated $4.89M and leaving 44,975 shares worth $804K. The position accounts for ﹤0.01% of the portfolio, ranked #2270.

Franklin Resources first reported a position in CAI in Q2 2025 and has held it in 4 quarters since. The position peaked at $14.1M in Q2 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Franklin Resources held 44,975 shares of Caris Life Sciences worth $804K as of Q1 2026.
  • Franklin Resources sold 223,640 Caris Life Sciences shares in Q1 2026, an estimated $4.89M.
  • Caris Life Sciences made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2270 holding.
  • Franklin Resources first reported a position in Caris Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Franklin Resources's Caris Life Sciences position peaked at $14.1M in Q2 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.